DENTSPLY SIRONA Inc. $XRAY Shares Acquired by Quantbot Technologies LP

Quantbot Technologies LP lifted its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 51.0% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 411,976 shares of the medical instruments supplier’s stock after buying an additional 139,127 shares during the period. Quantbot Technologies LP owned approximately 0.21% of DENTSPLY SIRONA worth $6,155,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in the business. Vanguard Group Inc. lifted its position in DENTSPLY SIRONA by 2.8% in the first quarter. Vanguard Group Inc. now owns 20,740,589 shares of the medical instruments supplier’s stock valued at $309,864,000 after purchasing an additional 557,329 shares during the period. Price T Rowe Associates Inc. MD lifted its position in DENTSPLY SIRONA by 18.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier’s stock valued at $238,186,000 after purchasing an additional 1,975,404 shares during the period. Fuller & Thaler Asset Management Inc. lifted its position in DENTSPLY SIRONA by 2.8% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 11,539,418 shares of the medical instruments supplier’s stock valued at $219,018,000 after purchasing an additional 314,343 shares during the period. Lazard Asset Management LLC lifted its position in DENTSPLY SIRONA by 23.0% in the fourth quarter. Lazard Asset Management LLC now owns 8,044,228 shares of the medical instruments supplier’s stock valued at $152,678,000 after purchasing an additional 1,505,928 shares during the period. Finally, Dimensional Fund Advisors LP lifted its position in DENTSPLY SIRONA by 21.9% in the fourth quarter. Dimensional Fund Advisors LP now owns 6,851,869 shares of the medical instruments supplier’s stock valued at $130,045,000 after purchasing an additional 1,230,944 shares during the period. Institutional investors and hedge funds own 95.70% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently commented on XRAY shares. Piper Sandler reduced their price objective on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a “neutral” rating for the company in a research report on Wednesday, April 30th. Stifel Nicolaus reduced their price objective on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a research report on Friday, August 8th. Wells Fargo & Company reduced their price objective on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating for the company in a research report on Friday, August 8th. Barrington Research set a $18.00 price target on shares of DENTSPLY SIRONA and gave the company an “outperform” rating in a research report on Friday, August 8th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of DENTSPLY SIRONA in a research report on Monday, July 21st. Twelve analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, DENTSPLY SIRONA presently has a consensus rating of “Hold” and an average price target of $18.64.

DENTSPLY SIRONA Trading Up 0.1%

Shares of DENTSPLY SIRONA stock opened at $13.86 on Tuesday. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. DENTSPLY SIRONA Inc. has a 1 year low of $12.16 and a 1 year high of $27.48. The company has a market capitalization of $2.76 billion, a P/E ratio of -2.92, a P/E/G ratio of 0.86 and a beta of 0.94. The business has a 50 day moving average price of $15.41 and a 200 day moving average price of $15.61.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%. The firm had revenue of $936.00 million during the quarter, compared to the consensus estimate of $929.67 million. During the same period in the previous year, the firm posted $0.49 EPS. The company’s quarterly revenue was down 4.9% compared to the same quarter last year. Sell-side analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 10th. Investors of record on Friday, September 26th will be given a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 4.6%. The ex-dividend date is Friday, September 26th. DENTSPLY SIRONA’s payout ratio is currently -13.50%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.